Professional Summary

Professional Overview

Aleksei Zeifman is an experienced Investment Director with a strong background in the pharmaceutical and biotechnology industries. He leverages his deep expertise in investment strategy, portfolio management, and business development to drive growth and innovation for the organizations he serves.

Experience Summary

Current Roles

As Investment Director at RV Invest and Vetter Pharma, Aleksei is responsible for sourcing, evaluating, and managing investment opportunities in the healthcare and life sciences sectors. He serves as a Board Member at Akribion Therapeutics and as a Board Observer at Alesta Therapeutics and Arda Therapeutics, providing strategic guidance and oversight to support the companies' growth initiatives.

Career Progression

Aleksei's career trajectory has been marked by progressive leadership roles within the investment and pharmaceutical domains. Prior to his current positions, he held various investment and advisory roles, leveraging his analytical skills and industry knowledge to contribute to the success of his employers and portfolio companies.

Academic Background

Aleksei holds a Master's degree in Finance and Investment from a leading European university, where he specialized in asset management and corporate finance. His academic achievements and specialized training have equipped him with the necessary skills and knowledge to excel in the investment management field.

Areas of Expertise

Aleksei's areas of expertise include investment strategy, portfolio management, due diligence, and business development. He has a deep understanding of the pharmaceutical and biotechnology industries, enabling him to identify and capitalize on emerging trends and investment opportunities. Additionally, Aleksei's strong analytical and problem-solving skills, coupled with his strategic mindset, make him a valuable asset in driving the growth and success of the organizations he serves.

Professional Impact

Throughout his career, Aleksei has played a pivotal role in shaping the investment strategies and portfolio compositions of leading healthcare and life sciences organizations. His contributions have directly contributed to the growth and development of numerous companies, with a focus on supporting innovation and driving positive outcomes for patients and stakeholders.

Conclusion

Aleksei Zeifman's extensive experience, industry expertise, and proven track record of success positions him as a highly sought-after Investment Director in the pharmaceutical and biotechnology sectors. His commitment to driving value through strategic investments and active portfolio management makes him a valuable asset to the organizations he serves.